Sterling Capital Management LLC Akero Therapeutics, Inc. Transaction History
Sterling Capital Management LLC
- $7.74 Trillion
- Q3 2024
A detailed history of Sterling Capital Management LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 207 shares of AKRO stock, worth $6,410. This represents 0.0% of its overall portfolio holdings.
Number of Shares
207Holding current value
$6,410% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AKRO
# of Institutions
176Shares Held
72.1MCall Options Held
178KPut Options Held
164K-
Wellington Management Group LLP Boston, MA7.9MShares$245 Million0.04% of portfolio
-
Janus Henderson Group PLC London, X07.08MShares$219 Million0.11% of portfolio
-
Rtw Investments, LP New York, NY5.92MShares$183 Million2.71% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$173 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$162 Million4.29% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $1.44B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...